CAS 84057-84-1 MFCD00865333-6-(2,3-Dichlorophenyl)-1,2,4-Triazine-3,5-Diamine 6-(2,3-二氯苯基)-1,2,4-三嗪-3,5-二胺 TAO{mole}

6-(2,3-Dichlorophenyl)-1,2,4-Triazine-3,5-Diamine 6-(2,3-二氯苯基)-1,2,4-三嗪-3,5-二胺

CAS 84057-84-1 MFCD00865333

化学结构图

SMILES: Nc1nnc(-c2cccc(Cl)c2Cl)[13c](N)n1

化学属性

Mol. Formula	C9H7Cl2N5
Mol. Weight	256.09
Melting Point	216-220

别名和识别编码

Chemical Name	6-(2,3-Dichlorophenyl)-1,2,4-Triazine-3,5-Diamine
Synonym	3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine, 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine GI 267119X BW 430C GI 267119X Lamictal Lamotrigine
PubChem Substance ID	160871245
EC Number	281-901-8
MDL Number	MFCD00865333
Chemical Name Translation	6-(2,3-二氯苯基)-1,2,4-三嗪-3,5-二胺
Beilstein Registry Number	7589268
CAS Number	84057-84-1
LabNetwork Molecule ID	LN00193340
Reaxys-RN	7589268
Merck Number	5353

信息真实价格透明资金保障专业采购外包团队在线服务

品牌质保精细包装现货库存一流品牌服务

安全信息

GHS Symbol

WGK Germany3

Hazard statements

H301 Toxic if swallowed 吞食有毒

Personal Protective Equipment Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

RTECSXY5850700

Precautionary statements

P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西，喝水或吸烟。
P301+P310
P301+P310+P330
P405 Store locked up. 上锁保管。
P501 Dispose of contents/container to..… 处理内容物/容器.....

Signal word Danger

Safety Statements

S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时，立即求医（可能时出示标签）；

Hazard Codes 6.1 T

Risk Statements

R25 Toxic if swallowed 吞咽有毒

UN Number 2811

Packing GroupIII

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - man
DOSE/DURATION           : 19 mg/kg
TOXIC EFFECTS :
   Behavioral - muscle contraction or spasticity
   Sense Organs and Special Senses (Eye) - effect, not otherwise specified
   Cardiac - EKG changes not diagnostic of specified effects
REFERENCE :
   LANCAO Lancet.  (7 Adam St., London WC2N 6AD, UK)  V.1-    1823-
   Volume(issue)/page/year: 342,1552,1993

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 245 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   EPILAK Epilepsia (New York).  (Raven Press, 1185 Ave. of the Americas, New
   York, NY 10036) Ser.1-3: 1909-55; Ser.4: V.1-    1959-
   Volume(issue)/page/year: 25,655,1984

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 205 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   EPILAK Epilepsia (New York).  (Raven Press, 1185 Ave. of the Americas, New
   York, NY 10036) Ser.1-3: 1909-55; Ser.4: V.1-    1959-
   Volume(issue)/page/year: 25,655,1984

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - woman
DOSE/DURATION           : 2 mg/kg/30H-I
TOXIC EFFECTS :
   Gastrointestinal - nausea or vomiting
   Kidney, Ureter, Bladder - changes in tubules (including acute renal failure,
   acute tubular necrosis)
REFERENCE :
   PEDIAU Pediatrics.  (American Academy of Pediatrics, P.O. Box 1034,
   Evanston, IL 60204) V.1-    1948-  Volume(issue)/page/year: 98,294,1996

Hazard Class6.1

Storage condition 0-10°C